Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55

1.

Increased Whole Blood Viscosity Is Associated with the Presence of Digital Ulcers in Systemic Sclerosis: Results from a Cross-Sectional Pilot Study.

Korsten P, Niewold TB, Zeisberg M, Utset TO, Cho D, Zachary LS, Sweiss NJ, Volkov S.

Autoimmune Dis. 2017;2017:3529214. doi: 10.1155/2017/3529214. Epub 2017 Nov 29.

2.

Serial FDG-PET/CT Imaging in the Management of Cardiac Sarcoidosis.

Bremer W, Sweiss NJ, Lu Y.

Clin Nucl Med. 2018 Feb;43(2):e50-e52. doi: 10.1097/RLU.0000000000001919.

PMID:
29215412
3.

FDG PET-CT findings of extra-thoracic sarcoid are associated with cardiac sarcoid: A rationale for using FGD PET-CT for cardiac sarcoid evaluation.

Patel DC, Gunasekaran SS, Goettl C, Sweiss NJ, Lu Y.

J Nucl Cardiol. 2017 Jul 5. doi: 10.1007/s12350-017-0962-4. [Epub ahead of print]

PMID:
28681340
4.

Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosis.

Singla S, Zhou T, Javaid K, Abbasi T, Casanova N, Zhang W, Ma SF, Wade MS, Noth I, Sweiss NJ, Garcia JG, Machado RF.

Pulm Circ. 2016 Dec;6(4):465-471. doi: 10.1086/688316.

5.
6.

Management of extrapulmonary sarcoidosis: challenges and solutions.

Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ.

Ther Clin Risk Manag. 2016 Nov 7;12:1623-1634. eCollection 2016. Review.

7.

Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction.

Murtagh G, Laffin LJ, Patel KV, Patel AV, Bonham CA, Yu Z, Addetia K, El-Hangouche N, Maffesanti F, Mor-Avi V, Hogarth DK, Sweiss NJ, Beshai JF, Lang RM, Patel AR.

Echocardiography. 2016 Sep;33(9):1344-52. doi: 10.1111/echo.13281.

8.

Sarcoid Pericarditis and Large Vessel Vasculitis Detected on FDG PET/CT.

Patel D, Xie K, Sweiss NJ, Lu Y.

Clin Nucl Med. 2016 Aug;41(8):661-3. doi: 10.1097/RLU.0000000000001267.

PMID:
27280907
9.
10.

FDG PET/CT Evidence of Effective Treatment of Cardiac Sarcoidosis With Adalimumab.

Miller CT, Sweiss NJ, Lu Y.

Clin Nucl Med. 2016 May;41(5):417-8. doi: 10.1097/RLU.0000000000001124.

PMID:
26828145
11.

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.

Murtagh G, Laffin LJ, Beshai JF, Maffessanti F, Bonham CA, Patel AV, Yu Z, Addetia K, Mor-Avi V, Moss JD, Hogarth DK, Sweiss NJ, Lang RM, Patel AR.

Circ Cardiovasc Imaging. 2016 Jan;9(1):e003738. doi: 10.1161/CIRCIMAGING.115.003738.

12.

Respiratory Distress and Nephropathy in a Young Male With Small-Joint Polyarthritis.

Korsten P, Konig MF, Müller GA, Barrantes-Freer A, Sweiss NJ, Vasko R.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1173-9. doi: 10.1002/acr.22781. No abstract available.

13.

MRI and FDG PET/CT imaging manifestations of cardiac sarcoidosis.

Lu Y, Sweiss NJ.

Clin Nucl Med. 2015 Dec;40(12):973-4. doi: 10.1097/RLU.0000000000000966.

PMID:
26544904
14.

Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol.

Moller DR, Koth LL, Maier LA, Morris A, Drake W, Rossman M, Leader JK, Collman RG, Hamzeh N, Sweiss NJ, Zhang Y, O'Neal S, Senior RM, Becich M, Hochheiser HS, Kaminski N, Wisniewski SR, Gibson KF; GRADS Sarcoidosis Study Group.

Ann Am Thorac Soc. 2015 Oct;12(10):1561-71. doi: 10.1513/AnnalsATS.201503-172OT.

15.

Response.

Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP.

Chest. 2015 Feb;147(2):e65-e66. doi: 10.1378/chest.14-2603. No abstract available.

16.

Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor.

Au S, Mirsaeidi M, Aronson IK, Sweiss NJ.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Oct 20;31(3):249-51.

17.

Racial difference in sarcoidosis mortality in the United States.

Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP.

Chest. 2015 Feb;147(2):438-449. doi: 10.1378/chest.14-1120.

18.

Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.

Sweiss NJ, Noth I, Mirsaeidi M, Zhang W, Naureckas ET, Hogarth DK, Strek M, Caligiuri P, Machado RF, Niewold TB, Garcia JG, Pangan AL, Baughman RP.

Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr 18;31(1):46-54.

19.

Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.

Cain MA, Metzl MD, Patel AR, Addetia K, Spencer KT, Sweiss NJ, Beshai JF.

Am J Cardiol. 2014 May 1;113(9):1556-60. doi: 10.1016/j.amjcard.2014.01.434. Epub 2014 Feb 12.

PMID:
24731652
20.

Tocilizumab in the treatment of rheumatoid arthritis and beyond.

Shetty A, Hanson R, Korsten P, Shawagfeh M, Arami S, Volkov S, Vila O, Swedler W, Shunaigat AN, Smadi S, Sawaqed R, Perkins D, Shahrara S, Sweiss NJ.

Drug Des Devel Ther. 2014 Mar 28;8:349-64. doi: 10.2147/DDDT.S41437. eCollection 2014. Review.

Supplemental Content

Loading ...
Support Center